Quarterly Result: Ipca Laboratories Ltd.
Bhagyashree Vivarekar / 12 Nov 2016
.png)
Ipca Laboratories Ltd., has ended at Rs. 599.7, up by 7.2 points or 1.22% from its earlier closing of Rs. 592.5 on the BSE.The company's net profit has upsurged 345% yoy to Rs 54.95 cr.
Technical View:
Ipca Laboratories Ltd., has ended at Rs. 599.7, up by 7.2 points or 1.22% from its earlier closing of Rs. 592.5 on the BSE.
The scrip touched a high and low of Rs. 618 and Rs. 583.8 respectively, after opening at 585.9. Altogether 666552(NSE+BSE) shares have been traded on the counter; and the stock is trading below its 50 DMA.
Standalone Results Q2FY17:
IPCA Laboratories Ltd’s Q2FY17 numbers have come in as a mixed bag in comparison to Bloomberg estimates. Revenue has come in 3.5% greater than the estimate of Rs 855 cr. EBITDA margin is greater by 361 bps from the estimate of 11%. Net profit has been reported 28% lesser than the estimated figure of Rs 76 cr.
The quarter's revenue has soared 17.4% yoy to Rs 885 cr.
Ipca's reported EBITDA has climbed 52.3% yoy to Rs 128 cr while EBITDA margins have improved by 331 bps yoy to 14%. This was supported by operational efficiency.
The company's net profit has upsurged 345% yoy to Rs 54.95 cr, majorly owing to foreign exchange gain of Rs 7.81 compared to loss of Rs 23.63 cr in Q2FY16.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.